What's breaking now, across thousands of outlets.
Revolution Medicines executives say they're ready to launch what is arguably the biopharma industry's most highly anticipated experimental therapy. The drug, daraxonrasib, is awaiting an approval decision from the US and Europe for metastatic pancreatic ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
The world's fastest-growing Ebola outbreak is spreading quicker than efforts to fight it, the head of the WHO said.
The world's fastest-growing Ebola outbreak is spreading quicker than efforts to fight it, the head of the World Health Organisation (WHO) said yesterday during a visit to the Democratic Republic of Congo where some health workers are striking over a lack of pay.
Earlier testing and easier access to care could help prevent liver cancer and premature deaths.
Findings published in the journal Annals of the Rheumatic Diseases underscore the importance for healthcare providers and policymakers to recognise the impact air pollution can have on how one manages…
The FDA has approved Moderna’s influenza vaccine, the first licensed flu shot made using messenger RNA technology.
The agency had initially refused to even review the application but reversed course after a public outcry.
